EP3946311A4 - Anesthetic composition and method of anesthetizing the eye - Google Patents
Anesthetic composition and method of anesthetizing the eye Download PDFInfo
- Publication number
- EP3946311A4 EP3946311A4 EP20776365.7A EP20776365A EP3946311A4 EP 3946311 A4 EP3946311 A4 EP 3946311A4 EP 20776365 A EP20776365 A EP 20776365A EP 3946311 A4 EP3946311 A4 EP 3946311A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- anesthetizing
- eye
- anesthetic composition
- anesthetic
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962824207P | 2019-03-26 | 2019-03-26 | |
PCT/US2019/024239 WO2019191200A1 (en) | 2018-03-27 | 2019-03-27 | Method and formulation for producing anesthesia of internal aspect of eye wall by topical application |
US16/811,798 US11096922B2 (en) | 2018-03-27 | 2020-03-06 | Anesthetic composition and method of anesthetizing the eye |
PCT/US2020/022915 WO2020197816A1 (en) | 2019-03-26 | 2020-03-16 | Anesthetic composition and method of anesthetizing the eye |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3946311A1 EP3946311A1 (en) | 2022-02-09 |
EP3946311A4 true EP3946311A4 (en) | 2022-12-28 |
Family
ID=72609654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20776365.7A Pending EP3946311A4 (en) | 2019-03-26 | 2020-03-16 | Anesthetic composition and method of anesthetizing the eye |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3946311A4 (en) |
JP (1) | JP2022527621A (en) |
KR (1) | KR20210143254A (en) |
CN (1) | CN114072139A (en) |
AU (1) | AU2020245203A1 (en) |
BR (1) | BR112021019039A2 (en) |
CA (1) | CA3134531A1 (en) |
IL (1) | IL286624A (en) |
MX (1) | MX2021011589A (en) |
SG (1) | SG11202110423UA (en) |
WO (1) | WO2020197816A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021903A1 (en) * | 1992-05-06 | 1993-11-11 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
CN101695488A (en) * | 2009-11-05 | 2010-04-21 | 蚌埠丰原涂山制药有限公司 | Compound articaine freeze-drying preparation for injection and preparation method thereof |
WO2018220288A1 (en) * | 2017-05-29 | 2018-12-06 | Tauzin Benedicte Vincente | Sterile injectable composition containing cross-linked hyaluronic acid and articaine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE547122T1 (en) * | 2001-11-21 | 2012-03-15 | Novartis Pharma Gmbh | COMPOSITION FOR STABILIZING HYALURONIC ACID |
CN101721407B (en) * | 2009-11-23 | 2013-04-10 | 蚌埠丰原涂山制药有限公司 | Compound articaine hydrochloride injection and preparation method thereof |
FR2968996B1 (en) * | 2010-12-17 | 2013-04-12 | Anteis Sa | AQUEOUS INJECTABLE STERILE FORMULATION USED IN OPHTHALMOLOGY |
FR3036035B1 (en) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC |
EP3347368A4 (en) * | 2015-09-08 | 2019-01-23 | Viewpoint Therapeutics, Inc. | Compounds and formulations for treating ophthalmic diseases |
-
2020
- 2020-03-16 JP JP2021560140A patent/JP2022527621A/en active Pending
- 2020-03-16 WO PCT/US2020/022915 patent/WO2020197816A1/en active Application Filing
- 2020-03-16 AU AU2020245203A patent/AU2020245203A1/en active Pending
- 2020-03-16 KR KR1020217034148A patent/KR20210143254A/en unknown
- 2020-03-16 BR BR112021019039A patent/BR112021019039A2/en unknown
- 2020-03-16 MX MX2021011589A patent/MX2021011589A/en unknown
- 2020-03-16 CA CA3134531A patent/CA3134531A1/en active Pending
- 2020-03-16 EP EP20776365.7A patent/EP3946311A4/en active Pending
- 2020-03-16 SG SG11202110423UA patent/SG11202110423UA/en unknown
- 2020-03-16 CN CN202080033483.9A patent/CN114072139A/en active Pending
-
2021
- 2021-09-23 IL IL286624A patent/IL286624A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021903A1 (en) * | 1992-05-06 | 1993-11-11 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
CN101695488A (en) * | 2009-11-05 | 2010-04-21 | 蚌埠丰原涂山制药有限公司 | Compound articaine freeze-drying preparation for injection and preparation method thereof |
WO2018220288A1 (en) * | 2017-05-29 | 2018-12-06 | Tauzin Benedicte Vincente | Sterile injectable composition containing cross-linked hyaluronic acid and articaine |
Non-Patent Citations (2)
Title |
---|
SCHNEIDER G: "[Experiences with carticain in anaesthesia prior to ophthalmic operation]. ERFAHRUNGEN MIT CARTICAIN BEI DER ANAESTHESIE VOR OPHTHALMOLOGISCHEN EINGRIFFEN", BERICHTE DER DEUTSCHEN OPHTHALMOLOGISCHEN GESELLSCHAFT, XX, DE, vol. 78, 1 January 1981 (1981-01-01), pages 909 - 910, XP008007513 * |
See also references of WO2020197816A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA3134531A1 (en) | 2020-10-01 |
EP3946311A1 (en) | 2022-02-09 |
MX2021011589A (en) | 2021-12-15 |
WO2020197816A1 (en) | 2020-10-01 |
KR20210143254A (en) | 2021-11-26 |
CN114072139A (en) | 2022-02-18 |
IL286624A (en) | 2021-10-31 |
JP2022527621A (en) | 2022-06-02 |
AU2020245203A1 (en) | 2021-11-11 |
SG11202110423UA (en) | 2021-10-28 |
BR112021019039A2 (en) | 2021-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3894343A4 (en) | Methods and compositions for delivery of carbon dioxide | |
EP3840730A4 (en) | Compositions for the delivery of therapeutic agents and methods of use and making thereof | |
EP3743074A4 (en) | Composition and method for reducing thrombocytopenia via the administration of plinabulin | |
EP3749403A4 (en) | Self-sanitizing respiratory assembly and methods of making and using the same | |
EP3740576A4 (en) | Therapeutic compositions and methods of making and using the same | |
EP3969597A4 (en) | Compositions and methods for the treatment of atpase-mediated diseases | |
EP4059926A4 (en) | Crystal form of tafamidis and preparation method therefor and use thereof | |
EP3897564A4 (en) | Silk-hyaluronic acid tissue fillers and methods of making and using the same | |
EP3812378A4 (en) | Crystal form of arn-509, preparation method therefor and use thereof | |
EP3920898A4 (en) | Methods and compositions for treating sleep apnea | |
EP3952721A4 (en) | Endoscope and method of use | |
EP3806845A4 (en) | Cannabinoid composition and methods of treatment using the same | |
EP4059051A4 (en) | Integrated assemblies and methods of forming integrated assemblies | |
EP3760191A4 (en) | Pharmaceutical composition and preparation method therefor and use thereof | |
EP4034109A4 (en) | Method and composition for the treatment of disease | |
EP4013445A4 (en) | Therapeutic protein compositions and methods | |
EP4069772A4 (en) | Kenaf-polyolefin composites and methods of making | |
EP4056683A4 (en) | Brain organoid and use thereof | |
EP4060022A4 (en) | Tonsilar organoid preparation method and use thereof | |
EP4017493A4 (en) | Methods of treatment using bcn057 and bcn512 | |
EP3996786A4 (en) | Respiratory assembly and methods of using the same | |
EP3976149A4 (en) | Respiratory assembly and methods of using the same | |
EP3923916A4 (en) | Injectable phenol formulations and methods of their use | |
EP3999851A4 (en) | Compositions and methods for the treatment of tuberculosis | |
EP3755407A4 (en) | Inhaler and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210928 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20221125 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 23/02 20060101ALI20221121BHEP Ipc: A61P 27/02 20060101ALI20221121BHEP Ipc: A61K 47/38 20060101ALI20221121BHEP Ipc: A61K 47/26 20060101ALI20221121BHEP Ipc: A61K 47/10 20170101ALI20221121BHEP Ipc: A61K 47/02 20060101ALI20221121BHEP Ipc: A61K 9/08 20060101ALI20221121BHEP Ipc: A61K 31/38 20060101ALI20221121BHEP Ipc: A61K 31/245 20060101ALI20221121BHEP Ipc: A61K 31/381 20060101AFI20221121BHEP |